This proprietary nature limits direct access to the model and imposes a cap on daily predictions.

HTL0027477, a Clinic-ready, First-in-Class Oral GPR35 Agonist for Inflammatory Bowel Disease Crinetics’ Once-Daily

valbenazine, a selective vesicular monoamine transporter 2 (VMAT2) inhibitor being investigated as a once-daily

The Neuromedin U system: pharmacological implications for the treatment of obesity and binge eating behavior

thuringiensis Cry4B toxin involves Na+/K+ ATPase GPCR Promiscuity Reshapes Islet Physiology TGR5 supresses cGAS/STING

A rational drug discovery campaign hinges on a deep understanding of how distinct molecules interact

Morgan Healthcare Conference Andrew Hopkins appointed CBE by HM King Charles III Voyager Therapeutics

., Ring, A.

Ping, Y.-Q., et al., Structural basis for the tethered peptide activation of adhesion GPCRs.

the observed phenotype since many glycosyltransferases and the two TPSTs also carry O-glycosylation (King

states: methods and implications The formation of functional complexes involving GPCRs and β-arrestins hinges